Table 1 Patient characteristics and laboratory findings at hospitalization
|  | Survivor group (n = 189) | cardiac death group (n = 9) | p-value* |
|---|---|---|---|
Age (years) | 65 ± 12 | 75 ± 12 | < 0.01 |
Male, n (%) | 156 (82.5) | 8 (88.9) | NS |
Body mass index (kg/m2) | 24.3 ± 3.3 | 22.4 ± 2.4 | NS |
Diabetes mellitus, n (%) | 34 (18.0) | 3 (33.3) | NS |
Dyslipidemia, n (%) | 152 (80.4) | 7 (77.8) | NS |
Hypertension, n (%) | 103 (54.5) | 5 (55.6) | NS |
Current smoker, n (%) | 63 (33.3) | 1 (11.1) | NS |
Family history of CAD, n (%) | 58 (30.7) | 1 (11.1) | NS |
Atrial fibrillation, n (%) | 18 (9.5) | 2 (22.2) | NS |
History of revascularization | |||
 PCI, n (%) | 31 (16.4) | 1 (11.1) | NS |
 CABG, n (%) | 7 (3.7) | 0 (0.0) | NS |
Systolic blood pressure (mmHg) | 139 ± 26 | 139 ± 36 | NS |
Diastolic blood pressure (mmHg) | 79 ± 19 | 79 ± 24 | NS |
Heart rate (/min) | 77 ± 17 | 88 ± 24 | NS |
LVEF (%) | 56.6 ± 11.7 | 47.7 ± 14.0 | 0.03 |
Total cholesterol (mg/dl) | 187 ± 43 | 168 ± 43 | NS |
Triglycerides (mg/dl) | 137 ± 95 | 108 ± 33 | NS |
HDL-cholesterol (mg/dl) | 46 ± 12 | 41 ± 15 | NS |
LDL-cholesterol (mg/dl) | 115 ± 39 | 105 ± 28 | NS |
eGFR (ml/min/1.73 m2) | 81.3 ± 20.4 | 68.1 ± 17.2 | NS |
Brain natriuretic peptide (pg/ml) | 151 ± 345 | 597 ± 882 | 0.03 |
Albumin (g/dl) | 4.0 ± 0.5 | 3.6 ± 0.7 | 0.01 |
Hemoglobin (g/dl) | 14.5 ± 1.7 | 13.0 ± 2.3 | 0.01 |
Hemoglobin A1c (%) | 5.8 ± 0.5 | 6.2 ± 0.6 | 0.02 |
1,5-AG (µg/ml) | 19.2 ± 7.7 | 12.3 ± 5.3 | < 0.01 |